Infectious diseases are medical conditions or disorders caused by microorganisms such as bacteria, fungi, viruses and other parasites. Several organisms are present in and on human bodies. Some organisms are normally harmless and even helpful. However, under certain circumstances, some organisms cause diseases. Infectious diseases spread from one person to another. Moreover, some are transmitted by bites from insects and animals. Infectious diseases also occur by consumption of contaminated food and water.
Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/infectious-disease-treatment/report-sample
Signs and symptoms of infectious diseases depend on the type of organism and infection. Some of the most common symptoms of infectious diseases include fatigue and fever. Mild complaints of infectious diseases treated from rest and home remedies, while some life-threatening infections require hospitalization. Infectious diseases, such chickenpox and measles are prevented by vaccination. Frequent and thorough hand-washing also protect human body from infectious diseases.
Moreover, anti-infective drugs play a vital role in the treatment of infectious diseases. Anti-infective drugs are used to kill and stop growth of microorganism. These drugs can act as a defense system for human body and neutralize the action of disease causative agents. Based on microorganism, anti-infective drugs are mainly categorized into antiviral, antibacterial, antifungal and antiparasitic drugs.
The global infectious disease treatment market is segmented into antibacterial drugs, antifungal drugs, antiviral drugs and antiparasitic drugs. Antibacterial drugs segment covers tetracyclines, beta-lactams, aminoglycosides, macrolides, phenicols, sulfonamides and quinolones. Antifungal segment includes azoles, echinodians, pyrimidines, polyenes and allylamines. Antiviral drugs segment covers HIV, hepatitis B and C treatment drugs.
For more information visit: https://www.psmarketresearch.com/market-analysis/infectious-disease-treatment
Some of the major competitors in the global infectious disease treatment market are F. Hoffmann-La Roche, GlaxoSmithKline, Merck, Johnson & Johnson, Pfizer, Gilead Sciences, Bristol-Myers Squibb Company, AstraZeneca, Bayer AG, Novartis, Sanofi, AbbVie and Auritec Pharmaceuticals.